Objectives: The cavum septi pellucidi (CSP) is an easily recognizable landmark in the fetal brain. CSP disappears after birth to form the septum pellucidum. Children with microdeletion 22q11 (del. 22q11) were, however, reported to have a persistent dilated CSP. This study was designed to examine whether the CSP is dilated in fetuses with del.22q11.
Methods: This was a case-control study where the CSP width was measured in normal fetuses from 16 to 34 weeks and in fetuses with del. 22q11. CSP width was correlated to the biparietal diameter (BPD). Reference curves were constructed, and z-scores calculated.
Results: Cavum septi pellucidi width in 260 normal fetuses showed a linear correlation with BPD. The study group consisted of 37 fetuses with del. 22q11. In 25/37 (67.5%) of fetuses with del. 22q11, the CSP was enlarged with a mean z-score of 2.64 (p < 0.0001). Fetuses with a BPD > 50 mm (>22 weeks of gestation) had a dilated CSP in 85.7% (24/28).
Conclusions: The CSP is a structure routinely evaluated in screening ultrasound. A wide CSP is found in second trimester fetuses with del. 22q11. A dilated CSP may be an important sonographic marker for the presence of del. 22q11 along with conotruncal malformations and thymic hypoplasia. © 2016 John Wiley & Sons, Ltd.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/pd.4911 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prenatal diagnosis and postnatal follow-ups of 38 clubfoot cases in a tertiary reference center.
Rev Assoc Med Bras (1992)
December 2024
University of Health Sciences, Turkish Ministry of Health Ankara City Hospital, Department of Obstetrics and Gynecology, Division of Perinatology - Ankara, Turkey.
Objective: The objective of this study was to evaluate the descriptive outcomes of 38 prenatally suspected clubfoot cases.
Methods: This is a retrospective cohort study conducted in Ankara Bilkent City Hospital's perinatology clinic. All consecutive cases with the diagnosis of fetal clubfoot between 2020 and 2023 were included.
Real-Life Functioning in 22q11.2 Deletion Syndrome in Relation to Neurocognitive Abilities and Psychotic Symptoms: A Comparison With Idiopathic Schizophrenia.
J Intellect Disabil Res
November 2024
Department of Human Neurosciences, Faculty of Medicine and Dentistry, Sapienza University of Rome, Rome, Italy.
Background: The 22q11.2 deletion syndrome (22q11.2DS) entails intellectual disabilities and higher risk of psychotic disorders.
View Article and Find Full Text PDFSensory Processing Challenges in Children with Neurodevelopmental Disorders and Genetic Conditions: An Observational Study.
NeuroSci
September 2024
Conecta Clínica-Centro de Desarrollo Infantil, 13001 Ciudad Real, Spain;
Article Synopsis
- * A study involving 614 children showed that those with neurodevelopmental disorders and genetic conditions faced more sensory processing difficulties compared to a control group, with unique challenges based on diagnosis.
- * The findings underline the need for early identification and customized interventions for sensory issues, as well as further research into the long-term effects of these interventions within broader therapeutic practices.
2q31 microdeletion syndrome with the velocardiofacial phenotype and review of the literature: a case report.
BMC Pediatr
October 2024
Congenital and rare disease center (CIACER), Universidad Icesi, Cali, Colombia.
Article Synopsis
- - The 2q31 deletion is linked to a specific set of features including developmental delays, short stature, distinct facial traits (like microcephaly and ear deformities), and limb defects, identified in 38 patients so far.
- - An 8-year-old girl with symptoms resembling velocardiofacial syndrome was diagnosed with a 2q31 microdeletion, confirmed through genetic testing that showed a non-continuous deletion between certain cytobands, along with treatment for her speech and swallowing difficulties.
- - This case is the first recorded instance of a complex deletion in the 2q31 regions, enhancing knowledge about the conditions linked to these genetic changes, and highlights the importance of advanced diagnostic methods to distinguish it
Prenatal cell-free DNA screening for chromosomal aneuploidies after euploid embryo transfer shows high concordance with preimplantation genetic testing for aneuploidy results and low positive predictive values.
Fertil Steril
December 2024
CReATe Fertility Centre, Toronto, Ontario, Canada; Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada; Department of Physiology, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada; Department of Obstetrics and Gynecology, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Article Synopsis
- The study aimed to assess the positive predictive value (PPV) of prenatal cell-free DNA (cfDNA) screening for detecting chromosomal abnormalities in pregnancies resulting from either in vitro fertilization or the transfer of untested embryos.
- Conducted at a fertility clinic, the research involved analyzing 2,973 cfDNA screening results for common trisomies and microdeletions, comparing outcomes between patients who underwent Preimplantation Genetic Testing for Aneuploidy (PGT-A) and those who did not.
- Results showed a high rate of cfDNA screening success (99.9%) with similar fetal fractions in both groups, and the study highlighted several positive screening results indicating chromosomal issues, emphasizing the
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!